Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patientsSophie A. Kurk, Anne M. May, Pim de Jong et al.|Journal of Cachexia Sarcopenia and Muscle|2019Cited by 107
Impact of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) on time to progression and overall survival (OS) in metastatic colorectal cancer (mCRC) patients.Sophie A. Kurk, Anne M. May, Petra H.M. Peeters et al.|Journal of Clinical Oncology|2017Cited by 6